Peker, E. Et Al. 2011. Incidence and Clinical Importance of Lupus Anticoagulant in Children With Recurrent Upper Respiratory Tract Infection. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , vol.17, no.2 , 220-224.

Peker, E., Kavakli, K., BALKAN, C., YILMAZ KARAPINAR, D., & Aydemir, B., (2011). Incidence and Clinical Importance of Lupus Anticoagulant in Children With Recurrent Upper Respiratory Tract Infection. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , vol.17, no.2, 220-224.

Peker, Erdal Et Al. "Incidence and Clinical Importance of Lupus Anticoagulant in Children With Recurrent Upper Respiratory Tract Infection," CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , vol.17, no.2, 220-224, 2011

Peker, Erdal Et Al. "Incidence and Clinical Importance of Lupus Anticoagulant in Children With Recurrent Upper Respiratory Tract Infection." CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , vol.17, no.2, pp.220-224, 2011

Peker, E. Et Al. (2011) . "Incidence and Clinical Importance of Lupus Anticoagulant in Children With Recurrent Upper Respiratory Tract Infection." CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , vol.17, no.2, pp.220-224.

@article{article, author={Erdal Peker Et Al. }, title={Incidence and Clinical Importance of Lupus Anticoagulant in Children With Recurrent Upper Respiratory Tract Infection}, journal={CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS}, year=2011, pages={220-224} }